Sign inJoin waitlistJoin the waitlist

Horatio Wildman

Residency Program Director · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital Residency
Present
New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Cornell University
2003–2006
Preliminary or Transitional Year
2002–2003
Renaissance School of Medicine at Stony Brook University
1998–2002
Duke University
1994–1998

Research

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
Annals of the Rheumatic Diseases · 2011 · 128 citations
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Arthritis & Rheumatology · 2018 · 117 citations
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Arthritis Research & Therapy · 2015 · 73 citations

Cynthia Magro
9 papers
Jessica Gordon
4 papers
Robert Spiera
4 papers
KN
Kristina Navrazhina
3 papers
Mary Crow
3 papers
CB
Claire Brown
2 papers
Jamie Mersten
2 papers · 1 as a resident
KC
Karen Chernoff
2 papers
SL
Shari Lipner
2 papers
BC
Brendan Camp
1 paper
BH
Brian Hibler
1 paper · 1 as a resident
BC
Brienne Cressey
1 paper · 1 as a fellow